NEVRO CORP. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 49 rows in 2016. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2016-12-05: Reporting owner Enxing Michael; Form 4; Security Stock Option (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2016-11-30: Reporting owner DEMANE MICHAEL F; Form 4; Security Stock Option (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2016-11-16: Reporting owner Schmitz Patrick; Form 4; Security Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2016-11-16: Reporting owner Enxing Michael; Form 4; Security Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2016-12-05 | Enxing Michael Officer (VP of Sales) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,500 80,108 owned after | $3.60 exercise price | 2016-12-07 | |
| 2016-11-30 | DEMANE MICHAEL F Director | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −10,000 54,501 owned after | $3.60 exercise price | 2016-12-02 | |
| 2016-11-16 | Schmitz Patrick Officer (Vice President, Operations) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +13,333 13,333 owned after | $87.62 exercise price | 2016-11-18 | |
| 2016-11-16 | Enxing Michael Officer (VP of Sales) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,000 10,000 owned after | $87.62 exercise price | 2016-11-18 | |
| 2016-11-16 | Alleavitch Doug Officer (VP, Quality) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +13,333 13,333 owned after | $87.62 exercise price | 2016-11-18 | |
| 2016-11-16 | Christoforou Christofer Officer (VP, Research & Development) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,000 10,000 owned after | $87.62 exercise price | 2016-11-18 | |
| 2016-11-16 | Galligan Andrew H Officer (Chief Financial Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +27,333 27,333 owned after | $87.62 exercise price | 2016-11-18 | |
| 2016-11-15 | Galligan Andrew H Officer (Chief Financial Officer) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,315 59,546 owned after | $3.60 exercise price | 2016-11-16 | |
| 2016-11-15 | Galligan Andrew H Officer (Chief Financial Officer) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −4,185 42,667 owned after | $18.00 exercise price | 2016-11-16 | |
| 2016-11-08 | DEMANE MICHAEL F Director | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −30,000 64,501 owned after | $3.60 exercise price | 2016-11-10 | |
| 2016-11-04 | Enxing Michael Officer (VP of Sales) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,500 81,608 owned after | $3.60 exercise price | 2016-11-08 | |
| 2016-10-10 | Elghandour Rami Director, Officer (President & CEO) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,000 75,051 owned after | $3.60 exercise price | 2016-10-12 | |
| 2016-10-06 | DEMANE MICHAEL F Director | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −27,754 84,613 owned after | $18.00 exercise price | 2016-10-06 | |
| 2016-10-06 | DEMANE MICHAEL F Director | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −18,750 81,250 owned after | $63.23 exercise price | 2016-10-06 | |
| 2016-10-05 | DEMANE MICHAEL F Director | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −17,587 94,501 owned after | $3.60 exercise price | 2016-10-06 | |
| 2016-10-05 | DEMANE MICHAEL F Director | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −28,918 112,367 owned after | $18.00 exercise price | 2016-10-06 | |
| 2016-10-04 | DEMANE MICHAEL F Director | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −46,505 112,088 owned after | $3.60 exercise price | 2016-10-06 | |
| 2016-10-04 | Enxing Michael Officer (VP of Sales) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,500 83,108 owned after | $3.60 exercise price | 2016-10-06 | |
| 2016-09-06 | Enxing Michael Officer (VP of Sales) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,500 84,608 owned after | $3.60 exercise price | 2016-09-08 | |
| 2016-08-23 holding as of filing | Christoforou Christofer Officer (VP, Research & Development) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $97.52 exercise price | 2016-08-23 | ||
| 2016-08-15 | Galligan Andrew H Officer (Chief Financial Officer) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −79 62,861 owned after | $3.60 exercise price | 2016-08-17 | |
| 2016-08-15 | Galligan Andrew H Officer (Chief Financial Officer) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,374 42,430 owned after | $3.60 exercise price | 2016-08-17 | |
| 2016-08-15 | Galligan Andrew H Officer (Chief Financial Officer) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −5,047 46,852 owned after | $18.00 exercise price | 2016-08-17 | |
| 2016-08-04 | Enxing Michael Officer (VP of Sales) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,500 86,108 owned after | $3.60 exercise price | 2016-08-05 | |
| 2016-07-05 | Enxing Michael Officer (VP of Sales) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,500 87,608 owned after | $3.60 exercise price | 2016-07-07 | |
| 2016-06-08 | Walker Andre Officer (Senior VP,Research&Development) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −6,000 29,422 owned after | $1.44 exercise price | 2016-06-10 | |
| 2016-06-08 | Elghandour Rami Director, Officer (President & CEO) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −7,000 78,051 owned after | $3.60 exercise price | 2016-06-10 | |
| 2016-06-06 | Enxing Michael Officer (VP of Sales) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,500 89,108 owned after | $3.60 exercise price | 2016-06-08 | |
| 2016-06-02 | Walker Andre Officer (Senior VP,Research&Development) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −764 35,422 owned after | $1.44 exercise price | 2016-06-03 | |
| 2016-06-01 | Walker Andre Officer (Senior VP,Research&Development) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,236 36,186 owned after | $1.44 exercise price | 2016-06-03 | |
| 2016-05-18 | Vale Brad Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +3,240 3,240 owned after | $63.39 exercise price | 2016-05-20 | |
| 2016-05-18 | McCormick Shawn Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +3,240 3,240 owned after | $63.39 exercise price | 2016-05-20 | |
| 2016-05-18 | JAEGER WILFRED E Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +3,240 3,240 owned after | $63.39 exercise price | 2016-05-20 | |
| 2016-05-18 | Fischer Frank M Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +3,240 3,240 owned after | $63.39 exercise price | 2016-05-20 | |
| 2016-05-18 | Earnhardt Lisa D Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +3,240 3,240 owned after | $63.39 exercise price | 2016-05-20 | |
| 2016-05-18 | Behbahani Ali Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +3,240 3,240 owned after | $63.39 exercise price | 2016-05-20 | |
| 2016-05-16 | Galligan Andrew H Officer (Chief Financial Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −10,000 27,404 owned after | $1.44 exercise price | 2016-05-18 | |
| 2016-05-12 | Elghandour Rami Officer (President) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,844 119,546 owned after | $3.60 exercise price | 2016-05-16 | |
| 2016-05-12 | Elghandour Rami Officer (President) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,156 85,051 owned after | $3.60 exercise price | 2016-05-16 | |
| 2016-05-04 | Enxing Michael Officer (VP of Sales & Marketing) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,500 90,608 owned after | $3.60 exercise price | 2016-05-06 | |
| 2016-04-04 | Enxing Michael Officer (VP of Sales & Marketing) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −8,767 92,108 owned after | $3.60 exercise price | 2016-04-05 | |
| 2016-04-01 | Elghandour Rami Officer (President) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −7,000 123,390 owned after | $3.60 exercise price | 2016-04-05 | |
| 2016-03-17 | Galligan Andrew H Officer (Chief Financial Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −25,500 37,404 owned after | $1.44 exercise price | 2016-03-21 | |
| 2016-03-14 | Schmitz Patrick Officer (Vice President, Operations) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,000 20,000 owned after | $57.89 exercise price | 2016-03-16 | |
| 2016-03-09 | Elghandour Rami Officer (President) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +202,294 202,294 owned after | $54.50 exercise price | 2016-03-11 | |
| 2016-03-09 | Elghandour Rami Officer (President) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +67,432 67,432 owned after | $54.50 exercise price | 2016-03-11 | |
| 2016-03-03 | Enxing Michael Officer (VP of Sales & Marketing) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −37,000 100,875 owned after | $3.60 exercise price | 2016-03-07 | |
| 2016-03-01 | Galligan Andrew H Officer (Chief Financial Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −10,000 62,904 owned after | $1.44 exercise price | 2016-03-03 | |
| 2016-01-11 | Walker Andre Officer (Senior VP,Research&Development) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −7,987 39,422 owned after | $1.44 exercise price | 2016-01-13 |